Gamified Occupational Therapy for Adolescents With Duchenne Muscular Dystrophy
- Sponsor
- Başak Çağla Arslan
- Study ID
- NCT06402942
- Status
- Recruiting
Conditions
- Duchenne Muscular Dystrophy
- Gamification
- Occupational Therapy
Eligibility Criteria
- Sex
- MALE
- Age
- 13 Years - 18 Years
- Healthy Volunteers
- Not accepted
Interventions
- Gamified occupational therapy programme — OTHERGamified occupational therapy program for the experimental group and classical occupational therapy program for the control group, which will be applied to both groups for eight weeks
- Classic occupational therapy programme — OTHERGamified occupational therapy program for the experimental group and classical occupational therapy program for the control group, which will be applied to both groups for eight weeks
Study Details
This research aims to improve the quality of life, occupational performance, occupational satisfaction and emotional health of young people with Duchenne muscular dystrophy compared to the classical occupational therapy program. The findings are planned to shed light on the development of new and effective strategies in the rehabilitation of adolescents with Duchenne muscular dystrophy.
Key Dates
- Start date
- May 1, 2025
- Status verified
- Jan 2026
- Primary completion
- Aug 21, 2026
- Completion
- Dec 8, 2026
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Experimental groupGamified occupational therapy programme group
- Other: Control groupClassic occupational therapy group
Primary Outcome Measure
Demographic information form [ Time Frame: At the start of the evaluations ]
Central Contacts
- Başak Çağla Arslan, Master Degree4448548
Related Studies
- Magnetic Resonance Imaging and Biomarkers for Muscular DystrophyRecruiting · University of Florida · Gainesville, Florida
- The Duchenne RegistryRecruiting · The Duchenne Registry · Washington D.C., District of Columbia
- Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability StudyPHASE2/PHASE3 · Recruiting · Italfarmaco · Sacramento, California
- Early Check: Expanded Screening in NewbornsEnrolling By Invitation · RTI International · Research Triangle Park, North Carolina